Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristian Strømgaard

Showing results (141-150 of 157) with videos related to

Pageof 16
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|February 21, 2012
A high-affinity, dimeric inhibitor of PSD-95 bivalently interacts with PDZ1-2 and protects against ischemic brain damageAnders Bach, Bettina H Clausen, Magda Møller, et al.
The Journal of Biological Chemistry|February 13, 2019
Rational design of a heterotrimeric G protein α subunit with artificial inhibitor sensitivityDavide Malfacini, Julian Patt, Suvi Annala, et al.
Elife|January 23, 2023
Soluble amyloid-β precursor peptide does not regulate GABA<sub>B</sub> receptor activityPascal Dominic Rem, Vita Sereikaite, Diego Fernández-Fernández, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2009
Identification of a small-molecule inhibitor of the PICK1 PDZ domain that inhibits hippocampal LTP and LTDThor S Thorsen, Kenneth L Madsen, Nelson Rebola, et al.
Journal of the American Chemical Society|January 5, 2021
Targeting the APP-Mint2 Protein-Protein Interaction with a Peptide-Based Inhibitor Reduces Amyloid-β FormationChristian R O Bartling, Thomas M T Jensen, Shawna M Henry, et al.
Journal of the American Chemical Society|March 20, 2025
eSylites: Synthetic Probes for Visualization and Topographic Mapping of Single Excitatory SynapsesChristiane Huhn, Sheng-Yang Ho, Clemens Schulte, et al.
Neuropharmacology|March 6, 2019
Selectivity, efficacy and toxicity studies of UCCB01-144, a dimeric neuroprotective PSD-95 inhibitorAnders Bach, Bettina H Clausen, Lotte K Kristensen, et al.
Science Advances|March 1, 2024
Targeting postsynaptic glutamate receptor scaffolding proteins PSD-95 and PICK1 for obesity treatmentNicole Fadahunsi, Jonas Petersen, Sophia Metz, et al.
Journal of Medicinal Chemistry|January 27, 2021
A High-Affinity Peptide Ligand Targeting Syntenin Inhibits GlioblastomaLinda M Haugaard-Kedström, Louise S Clemmensen, Vita Sereikaite, et al.
NPJ Parkinson'S Disease|July 29, 2024
Molecular properties and diagnostic potential of monoclonal antibodies targeting cytotoxic α-synuclein oligomersJanni Nielsen, Johanne Lauritsen, Jannik N Pedersen, et al.
Pageof 16

Showing results (141-150 of 157) with videos related to

Sort By:
Pageof 16
Proceedings of the National Academy of Sciences of the United States of America|February 21, 2012
A high-affinity, dimeric inhibitor of PSD-95 bivalently interacts with PDZ1-2 and protects against ischemic brain damageAnders Bach, Bettina H Clausen, Magda Møller, et al.
The Journal of Biological Chemistry|February 13, 2019
Rational design of a heterotrimeric G protein α subunit with artificial inhibitor sensitivityDavide Malfacini, Julian Patt, Suvi Annala, et al.
Elife|January 23, 2023
Soluble amyloid-β precursor peptide does not regulate GABA<sub>B</sub> receptor activityPascal Dominic Rem, Vita Sereikaite, Diego Fernández-Fernández, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2009
Identification of a small-molecule inhibitor of the PICK1 PDZ domain that inhibits hippocampal LTP and LTDThor S Thorsen, Kenneth L Madsen, Nelson Rebola, et al.
Journal of the American Chemical Society|January 5, 2021
Targeting the APP-Mint2 Protein-Protein Interaction with a Peptide-Based Inhibitor Reduces Amyloid-β FormationChristian R O Bartling, Thomas M T Jensen, Shawna M Henry, et al.
Journal of the American Chemical Society|March 20, 2025
eSylites: Synthetic Probes for Visualization and Topographic Mapping of Single Excitatory SynapsesChristiane Huhn, Sheng-Yang Ho, Clemens Schulte, et al.
Neuropharmacology|March 6, 2019
Selectivity, efficacy and toxicity studies of UCCB01-144, a dimeric neuroprotective PSD-95 inhibitorAnders Bach, Bettina H Clausen, Lotte K Kristensen, et al.
Science Advances|March 1, 2024
Targeting postsynaptic glutamate receptor scaffolding proteins PSD-95 and PICK1 for obesity treatmentNicole Fadahunsi, Jonas Petersen, Sophia Metz, et al.
Journal of Medicinal Chemistry|January 27, 2021
A High-Affinity Peptide Ligand Targeting Syntenin Inhibits GlioblastomaLinda M Haugaard-Kedström, Louise S Clemmensen, Vita Sereikaite, et al.
NPJ Parkinson'S Disease|July 29, 2024
Molecular properties and diagnostic potential of monoclonal antibodies targeting cytotoxic α-synuclein oligomersJanni Nielsen, Johanne Lauritsen, Jannik N Pedersen, et al.
Pageof 16